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Abstract:
The goal of this research is to develop a mouse model with a mutation in the CYP1B1
gene that would result in a phenotype similar to that seen in Primary Congenital Glaucoma
(PCG) human patients. Using this mouse model, structural changes in eyes and upregulation of
certain proteins were observed compared to a normal mouse. Examination of the cornea, iris,
retina, ciliary body, and iridocorneal angle showed structural changes in CYP1B1 mice compared
to wild type mice. These results were similar to those described in studies using other animal
models. Furthermore, the current study confirmed earlier findings in other animal models,
showing that P53 is upregulated in the cornea, retina, and iridocorneal angle of a CYP1B1 mutant
compared to the wild-type. This suggests that a mutation in the CYP1B1 gene in a mouse model
results in a phenotype similar to that seen in human patients with PCG. Therefore, this model
could be used to investigate possible treatments for PCG.

Introduction:
Glaucoma is the leading cause of blindness, affecting roughly 70 million people
worldwide (Quigley & Broman, 2006). Three major types of Glaucoma persist in the human
population: Primary Open Angle Glaucoma (POAG), Primary Angle Closure Glaucoma
(PACG), and Primary Congenital Glaucoma (PCG) (Bouhenni et al. 2012). Primary Congenital
Glaucoma (PCG) is the most prevalent form of pediatric glaucoma, affecting approximately 1 in
30,000 live births (Giampani & Giampani, 2011). PCG is an autosomal recessive disease
affecting the eye. If left untreated, PCG can cause visual impairment and blindness. Furthermore,
at least 50% of individuals with this disorder will become legally blind (Levy et al. 2005).
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PCG is present at birth, but symptoms may not be observed until infancy or early
childhood (Giampani & Giampani, 2011). PCG affects all races, but male patients are found to
have a higher incidence (Giampani & Giampani, 2011). Signs and symptoms include: excessive
tearing, sensitivity to light, spasms of the eye, enlarged eye, and cloudy appearance of the cornea
(Giampani & Giampani, 2011). There is currently no treatment for this disease other than
surgical procedures which can have further complications, and is not completely curative (Levy
et al. 2005). Current surgical procedures used are Goniotomy and trabeculotomy, with highest
success rates when PCG is detected earlier in development (Giampani & Giampani, 2011).
Three genes have been isolated as the most likely cause of this disorder: cytochrome p
450 b1 (CYP1B1), latent transforming binding protein 2 (LTBP2) and TEK (Bouhenni et al.
2012). This research specifically looks at the mutation of the CYP1B1 gene in mice. The
CYP1B1 gene is expressed in tissues of the anterior chamber of the eye (Sarfarazi & Stoilov,
2000). Mutations of this gene impact eye development, specifically in the cornea, iris, ciliary
body, and iridocorneal angle impacting flow of aqueous humor throughout the eye (Vasiliou &
Gonzalez, 2008). With the build-up of this fluid in the eye, patients have elevated intraocular
pressure, which creates pressure against the optic nerve, damaging retinal neurons in the eye
leading to visual impairment as well as the loss of retina cells. Currently, there is no ideal animal
model that captures the complexity of this disease in human patients (Bouhenni et al. 2012).

Methods:
Mouse Model: Eyes from mice carrying a mutation in CYP1B1 (Cyp1b1-/- ) were compared to
eyes from age-matched healthy mice (WT).
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Histology: Immediately after enucleation, eyes were fixed in 10% Buffered Neutral Formalin,
processed and fixed in paraffin. Paraffin blocks were cut into thin (6 μm) tissue sections using a
microtome and placed on pretreated glass slides.
Hematoxylin and Eosin (H&E) Staining: The sections were stained using H&E staining. Eosin
is an acidic dye that is negatively charged and stains basic structures red or pink (Fischer et al.
2008). Hematoxylin is a basic dye used to stain acidic structures purplish blue (Fischer et al.
2008). The staining makes it possible for the cells to be visible under a microscope.
Microscopy: H&E stained sections were examined using an Olympus bright field microscope at
10x and 20x magnifications. Images of the iridocorneal angle, cornea, and iris were qualitatively
compared between Cyp1b1-/- and WT mice.
Immunohistochemistry: The amount of protein P53 were examined between Cyp1b1-/- and WT
mice using DAPI (4′,6-diamidino-2-phenylindole) is a the blue-fluorescent DNA stain used and
CY3 (cyanine dye 3) as the green-fluorescent protein counterstain.
Statistical Analysis: The mean intensity of fluorescent light tagging the protein P53 by CY3
green counterstain was measured using ImageJ and were tested for statistical significance by an
ANOVA single factor test.
Results of H&E stained sections:
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Figure 1. Images of the cornea from (A) Cyp1b1-/- mutant mouse and (B) wild-type mouse. Images taken at 20x
magnification. Scale bar: 100 μm. Labels within the cornea are the following: (E) Epithelium, (S) Stroma, and (En)
Endothelium. Note the irregular organization of the collagen fibers in in the PCG corneal stroma (S) and a thicker
epithelium cell layer (E) compared to the wild-type cornea.

Figure 2. Images of the iris from (A) Cyp1b1-/- mouse and (B) wild-type mouse. Images taken at 10x
magnification. Scale bar: 100 μm. Labels within this image are the following: (I) Iris, (CB) Ciliary Body, (C)
Cornea. Note the density and lack of the iris process (I) in the Cyp1b1-/- mouse as well as the thick ciliary body
(CB) and cornea (C).

Figure 3. Images of the ciliary body (A) Cyp1b1-/- mouse and (B) wild-type mouse. Images taken at 20x
magnification. Scale bar: 100 μm. Labels within this image are the following: (I) Iris and (CB) Ciliary Body. Note
the altered structure of the ciliary body (CB) as it is compressed in the Cyp1b1-/- mouse compared to the wild-type
mouse.
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Figure 4. Images of iridocorneal angle histology of (A) Cyp1b1-/- mouse (B) wild-type mouse. Images taken at 20x
magnification. Scale bar: 100 μm. Labels within this image are the following: (R) Retina, (CB) Ciliary Body, (C)
Cornea, and (AC) Anterior Chamber Note the altered structure of the iridocorneal angle (arrow) of the Cyp1b1-/mutant mouse compared to the normal mouse angle (arrow). Cyp1b1-/- mouse has a smaller anterior chamber (AC)
and denser ciliary body (CB) when compared to the wild-type mouse.

Figure 5. Images of the retina (A) Cyp1b1-/- mouse and (B) wild-type mouse. Images taken at 20x magnification.
Scale bar: 100 μm. Note the layers of the retina, (1) sclera (2) choroid (3) photoreceptors (4) outer nuclear layer (5)
outer plexiform layer (6) inner nuclear layer (7) inner plexiform layer (8) ganglion cells, as it is more tightly packed
in the Cyp1b1-/- mouse compared to the wild-type mouse.

Analysis of H&E stained sections:
Differences between the cornea of a mutant mouse and a wild-type mouse were shown in
figure 1. Within the stroma of the mutant cornea, the collagen fibers were more condensed and
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did not show the typical organization as displayed in the wild-type stroma. The mutant cornea
also appeared to contain more stromal fibroblast cells, stained purple within the stroma,
compared to the wild-type mouse. The epithelial cell layer within the mutant is thicker and more
tightly packed with nuclei compared to the very organized epithelial layer observed in normal
mice. This may explain the loss of corneal transparency and corneal cloudiness that is observed
in PCG patients.

Differences between the irises of the Cyp1b1 mutant mouse and the wild-type mouse
were illustrated in figure 2. It was obvious that the iris was much thicker and denser in the
mutant mouse compared to the wild-type mouse. Furthermore, the mutant mouse’s iris was much
shorter and did not extend around the eye compared to the rich iris of the wild-type mouse. The
iris functions to insure passages of proper amounts of light into the eye, but in the mutant mouse
the iris muscle would be too dense to allow proper muscle contraction when exposed to light.
This may explain the observation that PCG patients have a higher sensitivity to light (reference).

Differences in the ciliary bodies of the mutant mouse and wild-type mouse were shown in
figure 3. The mutant mouse had much condensed ciliary body processes compared to the long
and differentiated processes of the wild-type mouse. It was also noted that the ciliary body in the
wild-type mouse was highly vascularized, shown by presence of pink blood vessels within the
processes. In contrast, little or no vascularization was observed in tightly pack ciliary bodies of
the mutant eye. The ciliary body plays an important role in the formation of the iridocorneal
angle, shown in Figure 4. The thick ciliary body, together with the abnormal iris, and cornea
formed a thick and immature angle, indicated by the arrow. The angle was much narrower and
the processes were much thicker compared to those of the wild-type. Furthermore, the anterior
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chamber of the eye was much larger in the wild-type mouse when compared to the mutant
mouse. This may explain why proper drainage of the aqueous fluid out of the eye is
compromised and interocular pressure rises in PCG patients. Analyzing the iridocorneal angle of
the wild-type mouse revealed that the cells were differentiated and the angle was open for proper
aqueous flow.

Figure 5 compares images taken from the retina of the mutant mouse and wild-type
mouse. The cellular layers of the retina within the mutant mouse were more tightly packed
together when compared to the wild-type mouse. The tight compact was specifically obvious in
the photoreceptor layer and the ganglion cell layer, two cellular layers crucial for transducing
light signals from the environment to nerve impulses in the optic nerve. The built-up pressure in
these areas would explain the eventually loss of vision if this condition were to persist, as the
cells are unable to function normally and die.
Results of Immunohistochemistry:
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Figure 6. Immunohistochemical detection of protein P53 within the cornea from (A) and (C) Cyp1b1-/- mutant
mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative control for
Cyp1b1-/- mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive control
tagged with antibody for P53 in Cyp1b1-/- mutant mouse, and Image (D) represents positive control for wild-type
mouse. Images taken at 20x magnification. Scale bar: 100 μm.

Cornea:
Average Intensity
Variance:
P-value:
Positive Cyp1b1 mouse (C)
40.612
0.47
4.80x10-5
Positive wild-type mouse (D)
32.379
1.33
Negative Cyp1b1 mouse (A)
33.435
0.47
Negative wildtype mouse (B)
34.229
1.33
Table 1: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from cornea samples
shown in Figure 6. Sample size (n=4). Data proved to be statistically significant between groups by ANOVA single
factor test (P-value: 4.80x10-5).

Figure 7. Immunohistochemical detection of protein P53 within the retina from (A) and (C) Cyp1b1-/- mutant
mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative control for
Cyp1b1-/- mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive control
tagged with antibody for P53 in Cyp1b1-/- mutant mouse, and Image (D) represents positive control for wild-type
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mouse. Images taken at 20x magnification. Scale bar: 100 μm.

Retina:
Positive Cyp1b1 mouse
Positive wild-type mouse
Negative Cyp1b1 mouse
Negative wildtype mouse

Average Intensity:
Variance:
P-value:
63.715
1.34
1.16x10-9
47.624
0.618
40.623
0.94
27.026
2.03

Table 2: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from retina samples
shown in Figure 7. Sample size (n=4). Data proved to be statistically significant between groups by ANOVA single
factor test (P-value: 1.16x10-9).

Figure 8. Immunohistochemical detection of protein P53 within the iridocorneal angle from (A) and (C) Cyp1b1-/mutant mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative
control for Cyp1b1-/- mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive
control tagged with antibody for P53 in Cyp1b1-/- mutant mouse, and Image (D) represents positive control for
wild-type mouse. Images taken at 20x magnification. Scale bar: 100 μm.
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Iridocorneal Angle:
Positive Cyp1b1 mouse
Positive wild-type mouse
Negative Cyp1b1 mouse
Negative wildtype mouse

Average Intensity:
Variance:
P-value:
62.124
0.501 2.31x10-13
28.029
0.239
15.375
0.258
24.024
0.051

Table 3: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from iridocorneal angle
samples shown in Figure 8. Sample size (n=4). Data proved to be statistically significant between groups by
ANOVA single factor test (P-value: 2.31x10-13).

Analysis of Immunohistochemistry:

Florescent images of the cornea, retina, and iridocorneal angle comparing the protein
levels of P53 with in the tissue revealed that the Cyp1b1-/- mutant mouse contained
significantly higher amounts. DAPI (4′,6-diamidino-2-phenylindole) was used as the bluefluorescent DNA stain and CY3 (cyanine dye 3) as the green-fluorescent protein counterstain
tagging P53. The intensity of green-fluorescent was measured using ImageJ as a measure for P53
within the tissue and compared using a single-factor ANOVA to prove statistical significance
between the negative and positive control for the Cyp1b1-/- mutant mouse and the negative and
positive control of the wild-type mouse. The highest mean intensity for the cornea was found to
be the positive control for the Cyp1b1-/- mutant mouse, 40.612. This value was statistically
significant from the negative controls and positive wild-type cornea with a p-value of 4.80x10-5.
Image C in Figure 6 showed the highly fluorescent stroma of the mutant cornea, while little or no
green fluorescent could be detected in the wild-type cornea.

Similarly, the highest mean intensity for the retina was found to be the positive control
for the Cyp1b1-/- mutant mouse, 63.715. This value was statistically significantly compared to
the other images taken from negative controls and the positive wild-type retina with a p-value of
1.16x10-9. P53 expression in the mutant mouse retina was high (staining intensity) in the
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photoreceptor layer, outer plexiform layer, and inner plexiform layer compared to the wild-type
retina that showed a faint fluorescent signal only in the photoreceptor layer (Fig. 7).

Lastly, the highest mean intensity for the iridocorneal angle was found to be the positive
control for the Cyp1b1-/- mutant mouse, 62.124. This value was also statistically significantly
larger than those from negative controls and the positive wild-type retina with a p-value of
2.31x10-13. In the mutant eye, strong P53 expression within the structures around the iridocorneal
angle: ciliary body, iris, and cornea, was observed (Fig. 8). In contrast, there was only faint P53
staining in those structures in the wild-type mouse eye. In summary, protein p53 was clearly
upregulated in the cornea, retina, and iridocorneal angle of mice with a mutation in the Cyp1b1
gene.

Discussion:

After analyzing and comparing images taken from sections of mice eyes with a mutation
in the Cyp1b1 gene to a normal wild-type mouse, it can be concluded that the mutation causes a
structural changes to the cornea, iris, retina, ciliary body, and iridocorneal angle. These changes
are similar to those found in human patients with PCG, blocking proper flow of aqueous humor
throughout the eye and causing blindness by build-up pressure against the optic nerve (Vasiliou
& Gonzalez, 2008). Mutations in the mouse Cyp1b1 gene also caused upregulation of the protein
P53. This is not surprising because P53 is believed to be a tumor/cancer suppressor, playing an
important role in regulating cell proliferation, and is upregulated in response to DNA and tissue
damages (Danilova et al. 2010). In summary, this study provides a mouse model with a mutation
in the CYP1B1 gene that results in a phenotype similar to that seen in human patients with PCG
and can be used to test alternative treatments for PCG.
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